Cargando…

Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers

BACKGROUND AND OBJECTIVE: Tucatinib is approved for treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer. Understanding potential drug–drug interactions (DDIs) informs proper dosing when co-administering tucatinib with other therapies. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Topletz-Erickson, Ariel, Lee, Anthony, Rustia, Evelyn L., Sun, Hao, Mayor, JoAl G., Abdulrasool, Layth I., Walker, Luke, Endres, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553805/ https://www.ncbi.nlm.nih.gov/pubmed/35931943 http://dx.doi.org/10.1007/s40262-022-01144-z

Ejemplares similares

The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment
por: Topletz-Erickson, Ariel R., et al.
Publicado: (2022)

Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers
por: Topletz-Erickson, Ariel R., et al.
Publicado: (2023)

Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects
por: Topletz‐Erickson, Ariel R., et al.
Publicado: (2020)

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
por: Lin, Nancy U., et al.
Publicado: (2020)

The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer
por: Sirhan, Zaid, et al.
Publicado: (2022)

Drug-Drug Interaction Analysis of Pyronaridine/Artesunate and Ritonavir in Healthy Volunteers
por: Morris, Carrie A., et al.
Publicado: (2012)

Drug‐Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
por: Bashir, Babar, et al.
Publicado: (2018)

Reviewing the role of healthy volunteer studies in drug development
por: Karakunnel, Joyson J., et al.
Publicado: (2018)

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers
por: Lesko, Lawrence J., et al.
Publicado: (2017)

Evaluation of drug interactions of saxagliptin with sildenafil in healthy volunteers
por: Mansour, Rania Y., et al.
Publicado: (2022)

Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers
por: Ribeiro, Isabela, et al.
Publicado: (2021)

Napabucasin Drug‐Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers
por: Dai, Xiaoshu, et al.
Publicado: (2021)

Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2020)

Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers
por: Kuchewar, Vaishali V., et al.
Publicado: (2014)

Healthy Volunteer Studies in the Development of Anticancer Drugs with Genotoxic Findings
por: Omes-Smit, Grace, et al.
Publicado: (2021)

Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2022)

Treating Advanced Unresectable or Metastatic HER2-Positive Breast Cancer: A Spotlight on Tucatinib
por: Ulrich, Lara, et al.
Publicado: (2021)

Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers
por: Dutreix, Catherine, et al.
Publicado: (2013)

Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders
por: Johansson, Susanne, et al.
Publicado: (2016)

Altered Microbial Composition of Drug-Sensitive and Drug-Resistant TB Patients Compared with Healthy Volunteers
por: Valdez-Palomares, Fernanda, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
por: Kim, Dasohm, et al.
Publicado: (2023)

Evaluation of the inhibitory effect of quercetin on the pharmacokinetics of tucatinib in rats by a novel UPLC–MS/MS assay
por: Zhang, Ying, et al.
Publicado: (2022)

Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer
por: Corti, C., et al.
Publicado: (2021)

The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis
por: Antonazzo, Ippazio Cosimo, et al.
Publicado: (2023)

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
por: Kang, Woo Youl, et al.
Publicado: (2020)

Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development
por: Ahmed, Mariam A., et al.
Publicado: (2019)

Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
por: Park, Jungsin, et al.
Publicado: (2017)

Healthy volunteers in first‐in‐human oncology drug development for small molecules
por: de las Heras, Begoña, et al.
Publicado: (2021)

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers
por: Anderson, Matt S., et al.
Publicado: (2017)

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2014)

Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers
por: Booij, L, et al.
Publicado: (2016)

Evaluation of Pharmacokinetic Drug Interactions Between Gemigliptin (Dipeptidylpeptidase-4 Inhibitor) and Glimepiride (Sulfonylurea) in Healthy Volunteers
por: Choi, Hee Youn, et al.
Publicado: (2014)

Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects
por: Mallikaarjun, Suresh, et al.
Publicado: (2016)

Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo‐controlled drug–drug interaction study
por: Spyker, Daniel A., et al.
Publicado: (2015)

Semimechanistic Population Pharmacokinetic Model to Predict the Drug–Drug Interaction Between S‐ketamine and Ticlopidine in Healthy Human Volunteers
por: Ashraf, Muhammad W., et al.
Publicado: (2018)

Concomitant Intake of Coca‐Cola to Manage the Drug–Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers
por: van Seyen, Minou, et al.
Publicado: (2019)

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers
por: Chilengi, Roma, et al.
Publicado: (2011)

Modelling the structural and reactivity landscapes of tucatinib with special reference to its wavefunction-dependent properties and screening for potential antiviral activity
por: Alsalme, Ali, et al.
Publicado: (2020)

Evaluation of the safety, pharmacokinetics, pharmacodynamics, and drug-drug interaction potential of a selective Lp-PLA2 inhibitor (GSK2647544) in healthy volunteers
por: Wu, Kai, et al.
Publicado: (2016)

Phase I clinical trials of anticancer drugs in healthy volunteers: Need for critical consideration
por: Gupta, Pooja, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d09sq6b6l2hquqvvptnhirnviu